Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intellia Aktie: FDA-Schock!


Der Gentherapie-Spezialist Intellia Therapeutics erlebt den Super-GAU: Die US-Arzneimittelbehörde FDA verhängte einen klinischen Stopp…

Der Beitrag Intellia Aktie: FDA-Schock! erschien zuerst auf kapitalmarktexperten.de.


Quelle kapitalmarktexperten.de

Intellia Therapeutics Inc Stock

€11.08
-1.690%
A loss of -1.690% shows a downward development for Intellia Therapeutics Inc.
Our community is currently high on Intellia Therapeutics Inc with 25 Buy predictions and 6 Sell predictions.
Based on the current price of 11.08 € the target price of 25 € shows a potential of 125.63% for Intellia Therapeutics Inc which would more than double the current price.

Comments